Trial intelligence / Profile preview

Intranasal cyanocobalamin regimens for vitamin B12 deficiency in elderly

2013-000356-18Phase 4Completed

Sponsor
SAHZ
Start
Jan 2014
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of cyanocobalamin in vitamin B12 deficiency (2 arms), sponsored by SAHZ. Primary endpoints: Change in serum total transcobalamin concentration over time and Change in serum holotranscobalamin (holoTC) concentration over time. Started Jan 2014; status: completed.

02

Drugs

cyanocobalamin
03

Conditions

vitamin B12 deficiency

Beyond the preview

Go deeper on 2013-000356-18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-000356-18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call